Unione Europea -
norvegese -
EMA (European Medicines Agency)
gavreto
roche registration gmbh - pralsetinib - karsinom, ikke-småcellet lunge - antineoplastiske midler - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
Norvegia -
norvegese -
Statens legemiddelverk
lilinorm 5 mg
ace pharmaceuticals bv - hydrokortison - tablett, filmdrasjert - 5 mg
Norvegia -
norvegese -
Statens legemiddelverk
lilinorm 5 mg / 10 mg
ace pharmaceuticals bv - hydrokortison - tablett, filmdrasjert - 5 mg / 10 mg
Norvegia -
norvegese -
Statens legemiddelverk
lilinorm 1 mg
ace pharmaceuticals bv - hydrokortison - tablett, filmdrasjert - 1 mg